RxSight Inc (NASDAQ: RXST) is 26.12% higher on its value in year-to-date trading and has touched a low of $22.91 and a high of $66.54 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RXST stock was last observed hovering at around $54.73 in the last trading session, with the day’s loss setting it -3.88%.
Currently trading at $50.85, the stock is 0.25% and -0.98% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.29 million and changing -7.09% at the moment leaves the stock -3.84% off its SMA200. RXST registered 103.08% gain for a year compared to 6-month loss of -17.21%. The firm has a 50-day simple moving average (SMA 50) of $51.4256 and a 200-day simple moving average (SMA200) of $52.858826.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 3.06% gain in the last 1 month and extending the period to 3 months gives it a 0.24%, and is 0.38% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.46% over the week and 3.57% over the month.
RxSight Inc (RXST) has around 374 employees, a market worth around $2.02B and $115.18M in sales. Profit margin for the company is -31.93%. Distance from 52-week low is 121.96% and -23.58% from its 52-week high. The company has generated returns on investments over the last 12 months (-12.86%).
The EPS is expected to grow by 40.26% this year
303.0 institutions hold shares in RxSight Inc (RXST), with institutional investors hold 94.53% of the company’s shares. The shares outstanding are 39.68M, and float is at 37.66M with Short Float at 5.82%. Institutions hold 89.66% of the Float.
The top institutional shareholder in the company is RA CAPITAL MANAGEMENT, L.P. with over 3.69 million shares valued at $222.32 million. The investor’s holdings represent 10.0285 of the RXST Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 2.4 million shares valued at $144.44 million to account for 6.5154 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 2.01 million shares representing 5.45 and valued at over $120.82 million, while LORD, ABBETT & CO. LLC holds 4.7099 of the shares totaling 1.74 million with a market value of $104.41 million.
RxSight Inc (RXST) Insider Activity
RxSight Inc disclosed in a document filed with the SEC on Nov 04 ’24 that Goldshleger Ilya () sold a total of 3,100 shares of the company’s common stock. The trade occurred on Nov 04 ’24 and was made at $51.05 per share for $0.16 million. Following the transaction, the insider now directly holds 42246.0 shares of the RXST stock.
Still, SEC filings show that on Nov 04 ’24, ILYA GOLDSHLEGER (Officer) Proposed Sale 3,100 shares at an average price of $51.05 for $0.16 million. The insider now directly holds shares of RxSight Inc (RXST).
